The FDA has lifted a recall affecting Custom Ultrasonics’ automated endoscope reprocessors while the company carries out corrective actions, the company announced Monday.
The FDA ordered Custom Ultrasonics to recall its AERs last November, following a slew of infection outbreaks related to duodenoscopes, according to a company statement.
Moving forward, the company is working with the agency to correct its procedures and protocols. The lift does not apply to duodenoscopes. — Anisa Jibrell